Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial

Objectives To determine the respective efficacy of quetiapine and rivastigmine for agitation in people with dementia in institutional care and to evaluate these treatments with respect to change in cognitive performance. Design Randomised double blind (clinician, patient, outcomes assessor) placebo...

Descripció completa

Dades bibliogràfiques

Publicat a:	BMJ
Autors principals:	Ballard, Clive, Margallo-Lana, Marisa, Juszczak, Edmund, Douglas, Simon, Swann, Alan, Thomas, Alan, O'Brien, John, Everratt, Anna, Sadler, Stuart, Maddison, Clare, Lee, Lesley, Bannister, Carol, Elvish, Ruth, Jacoby, Robin
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2005
Matèries:	Papers
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC556156/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15722369/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38369.459988.8F
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!